SUBSCRIBERS
TPG completes A$279m acquisition of Healthscope's Asian pathology labs
Asian pathology operations contributed EBITDA of A$18.2 million in FY17 and A$9.6 million in 1H18
Add BT as a preferred source
Claudia Chong
Published Fri, Aug 17, 2018 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
TPG Capital Asia on Friday announced that it has fully acquired Healthscope Limited's Asian pathology laboratories, including Singapore's Quest Laboratories, for a total of A$279 million (S$279 million).
Healthscope, which is an Australian private healthcare provider listed on the ASX, had 39 pathology laboratories across Singapore, Malaysia and Vietnam. In Singapore and Vietnam, these laboratories operate under the brand Quest Laboratories, while in Malaysia, they are known as Gribbles Pathology.
Copyright SPH Media. All rights reserved.
